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ABSTRACT
The glial fibrillary acidic protein, GFAP, forms
the intermediate cytoskeleton in cells of the glial
lineage. Besides the common GFAPa transcript, the
GFAPe and GFAPi transcripts are generated by
alternative mRNA 3’-end processing. Here we use
a GFAP minigene to characterize molecular
mechanisms participating in alternative GFAP
expression. Usage of a polyadenylation signal
within the alternatively spliced exon 7a is essential
to generate the GFAPi and GFAPi transcripts. The
GFAPi mRNA is distinct from GFAPe mRNA given
that it also includes intron 7a. Polyadenylation at the
exon 7a site is stimulated by the upstream splice
site. Moreover, exon 7a splice enhancer motifs
supported both exon 7a splicing and polyadenyla-
tion. SR proteins increased the usage of the exon 7a
polyadenylation signal but not the exon 7a splicing,
whereas the polypyrimidine tract binding (PTB)
protein enhanced both exon 7a polyadenylation
and exon 7a splicing. Finally, increasing transcrip-
tion by the VP16 trans-activator did not affect the
frequency of use of the exon 7a polyadenylation
signal whereas the exon 7a splicing frequency was
decreased. Our data suggest a model with the
selection of the exon 7a polyadenylation site being
the essential and primary event for regulating GFAP
alternative processing.
INTRODUCTION
The Glial Fibrillary Acidic Protein (GFAP) gene is
located on the human chromosome 17 (17q21), spanning
10kb, and consisting of 9 exons. The corresponding
GFAP protein is the principal intermediary cytoskeletal
ﬁlament in mature astrocytes of the central nervous
system (1). All intermediate ﬁlaments share a structure
consisting of a conserved a-helical rod-like middle
domain ﬂanked by non-helical head and tail domains
(2,3). Several isoforms of GFAP mRNA have been
identiﬁed in mammals. Compared to the common form
of GFAP, GFAPa, the mouse GFAPb and GFAPg
isoforms (4) are produced by using diﬀerent transcrip-
tional start sites. The GFAPd mRNA identiﬁed in the
rat is the result of an alternative splicing event in intron 7
including the last 1255nt of intron 7 fused to exon 8 (5).
Finally, the GFAPe isoform found in humans is produced
by the removal of an alternative exon 7a embedded in
intron 7 (6). Importantly, this exon 7a contains an
intrinsic polyadenylation signal. The GFAPe protein has
a C-terminal sequence similar to GFAPd (6). The GFAPe
C-terminus speciﬁcally binds to the transmembrane
proteins presenilin 1 and 2 (6). Furthermore, GFAPe
cannot form homodimers, as can GFAPa, but it is
capable of forming heterodimers with GFAPa and in
this way to be integrated into intermediate ﬁlaments (7).
The relative amounts of the two protein isoforms
appear to directly inﬂuence the stability of the inter-
mediate ﬁlaments (7,8). The GFAPe isoform is expressed
most prominently in astrocytes of the subventricular
zone of the brain, which is the principal source of neural
stem cells in the adult human brain. GFAPe could be an
important marker of neuronal stem cells and inﬂuence
their functions (8). Recently, another GFAP mRNA
isoform, GFAPk, was identiﬁed in humans (9). The
GFAPk mRNA is produced by including intron 7
sequences and polyadenylation in exon 7a. The open
reading frame of GFAPk contains a stop codon in the
included intron 7 sequences, and thus the GFAPk
protein diﬀers from GFAPa in the C-terminal. Also, the
relative amounts of the GFAPa and GFAPk proteins
appear to directly inﬂuence the stability of intermediate
ﬁlaments. The mRNA ratio of GFAPk/GFAPe is
decreased during cortex development and increased
in glioblastoma tumours, which indicates that the
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cell diﬀerentiation (9).
Alternative usage of splicing and polyadenylation
sequences frequently occurs in mammalian genes (10,11).
Seventy-four percent of human multi-exon genes are
estimated to be alternatively spliced (12), and the presence
of two or more alternatively used poly(A) signals is
estimated to occur in 49% of human genes (13).
Regulation of alternative splicing and polyadenylation
is controlled by sequences in the pre-mRNA (cis-elements)
and interacting trans-factors (RNA or protein). Essential
factors for splicing are the 50-exon–intron splice site
marked by the consensus sequence AG
 GURAGU
(
 =splice site, R=purine), the 30-splice site NYAG
 R
(Y=pyrimidine, N=purine or pyrimidine) preceded
by a pyrimidine-rich stretch and the branch point
sequence CURAY upstream of the 30-splice site (14,15).
Polyadenylation involves cleavage of the pre-mRNA
and subsequent addition of 200–300 adenosine resi-
dues (16). Cis-elements in the pre-mRNA direct
the factors to the correct cleavage site. Important is a
highly conserved hexanucleotide AAUAAA located at
11–23nt upstream of the cleavage site, and a less
conserved G/U-rich downstream element. The
mammalian cleavage and polyadenylation machinery
consists of the cleavage/polyadenylation speciﬁcity factor
(CPSF), cleavage stimulation factor (CstF), symplekin,
cleavage factor I and IIm (CF Im and CF IIm), poly(A)
polymerase (PAP), poly(A)-binding protein nuclear 1
(PABPN1) and the CTD of RNA polymerase II (15).
One of the best-elucidated mechanisms of alternative
poly(A) site selection comes from studies of the
immunoglobulin M (Ig m) pre-mRNA. During B-cell
maturation to plasma B cells there is a switch from a
membrane-bound (mm) Ig m to a secreted-form (ms) due to
competing splicing (mm) and polyadenylation at an early
polyadenylation site (ms). The mm polyadenylation site has
a stronger binding aﬃnity to CstF-64 than the ms site,
meaning that the mm site is favoured in the case of a
limited CstF-64 amount (17,18). The level of CstF-64 is
increased during B-cell maturation and the use of the
proximal ms polyadenylation site is favoured instead
(17,18).
There are several examples of how the regulation of
splicing of the terminal intron is coupled to 30-end
processing. Mutations of either the pyrimidine tract or
the 30-splice site of the last intron decrease the poly-
adenylation, and mutation of the AAUAAA decreases
the splicing eﬃciency in vitro (19–21). In vivo, sequences
within the last intron facilitate 30-end formation (22) and
more speciﬁcally, the pyrimidine tract in the terminal
intron of the human b-globin gene stimulates polyadeny-
lation both in vitro and in vivo (23). Several explanations
of this coupling have been suggested. For example,
poly(A) polymerase (PAP) interacts with U2AF
65
in vitro and stimulates the binding of U2AF
65 to a weak
pyrimidine tract of a terminal intron (24), and U2AF
65
also interacts with CF Im and stimulates 30-end cleavage
and polyadenylation in vitro (25). Moreover, interactions
between the U1 and U2 snRNPs and polyadenylation
factors may contribute to the coupling of splicing and
30-end formation; the U1A protein of the U1 snRNP
interacts with CPSF160 (26), and the U2 snRNP to CPSF
(27) and both events stimulate 30-end formation in vitro.
In addition to alternative splicing and polyadenylation
signal selection regulation through mRNA stability
is also involved in the control of cellular mRNA levels
(28). For example in activated B cells, the stability of the
mm mRNA is increased compared to the stability in
resting cells equalling the stability of the ms mRNA (29).
Thus, besides alternative splicing and polyadenylation
mRNA stability also participates in the regulation of mm
mRNA. mRNA cis-sequences and the length of the
poly(A) tail are important determinants for the control
of stability (30).
In this study, we have investigated the interplay between
alternative splicing and polyadenylation of the GFAP
pre-mRNA, which serves to generate the three isoforms
of GFAP: GFAPa, GFAPe and GFAPk. We ﬁnd an
intimate coupling between GFAP transcriptional activity,
alternative splicing and polyadenylation.
MATERIALS AND METHODS
Sequences of primers and siRNAs are available as
Supplementary Table S1.
Construction ofminigenes
The GFAP wt minigene was constructed by inserting
nucleotides 4677–10143 of the GFAP gene into the
pTAG4 expression vector. DNA extracted from a
Caucasian male was used as template in the PCR
reactions. The GFAP-part of the construct was made in
two parts and afterwards ligated together. The ﬁrst part
was generated using Taq DNA Polymerase (Amersham
Biosciences), forward primer hsGFAP4677f (number
included in the primer names indicate position in
the GFAP gene sequence GeneID 2670 in GeneBank)
carrying EcoRI site in the 50-end, and reverse primer
GFAP6061r carrying BglII site at the 50-end. PCR
conditions: 958C3 0 s ,6 0 8C3 0 s ,7 2 8C 3min; 35 cycles.
The second part was made using Phusion High Fidelity
DNA polymerase (Finnzymes), forward primer
hsGFAP6062f with a BglII site at the 50-end, and reverse
primer hsGFAP10143r placed 290bp downstream of
the poly(A) site in exon 9 with a NotI site at the 50-end.
PCR conditions: 988C1 0s ,7 1 8C3 0s ,7 2 8C 40s; 30 cycles.
The two GFAP-parts were inserted one at a time into
the pTAG4 expression vector and veriﬁed by sequencing.
The GFAP+1828bp minigene was constructed by
adding 1828bp representing genomic sequences located
downstream to the GFAP gene sequence present in
the GFAP wt minigene. Forward primer was
hsGFAP10144f and reverse hsGFAP11971r both carrying
NotI sites, and Phusion High Fidelity DNA polymerase.
PCR conditions: 988C1 0s ,7 1 8C3 0s ,7 2 8C 30s; 34 cycles.
The minigenes carrying other promoters than the
SV40 promoter were constructed from the GFAP wt
minigene. The SV40 promoter and its enhancer
sequences were removed from the GFAP wt minigene
and an AscI site added by site directed mutagenesis
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delSV40f and reverse pTAG4delSV40r.
The b-globin and the tk promoters were ampliﬁed by
PCR, by forward primer promoterf, reverse CATr, and
using Taq DNA Polymerase. PCR conditions: 958C3 0s ,
608C3 0s ,7 2 8C 3min; 30 cycles.
The GFAP promoter sequence including 2177bp
upstream of the start codon until 76bp downstream
of the start codon was ampliﬁed from human genomic
DNA by PCR using Phusion High Fidelity DNA
polymerase. Primers were GFAP-2177f and GFAP+76r.
PCR conditions: 988C1 0 s ,7 1 8C3 0 s ,7 2 8C 1min; 30
cycles. The SR protein expressing vectors were gifts (see
Acknowledgments section) and the VP16 plasmid
described before (31).
Site-directed mutagenesis
An overview of the mutations in the minigenes is available
in Supplementary Figure S1. The mutated minigenes were
made by site-directed mutagenesis. All reactions with
plasmids <10kb were performed under conditions:
2.5U PfuTurbo DNA Polymerase (Stratagene), 10pmol
of each primer, 10nmol dNTP, 5ml1 0   Reaction Buﬀer
(Stratagene), 20ng template and ddH2O to a total volume
of 50ml. Cycle conditions: (808C 5min 958C 30s), 958C
30s, 508C 1min, 688C 18min; 20 cycles. All reactions with
plasmids >10kb were performed under conditions: 5U
PfuTurbo DNA Polymerase, 10pmol of each primer,
20nmol dNTP, 5ml1 0   Reaction Buﬀer, 20ng template
and ddH2O to a total volume of 50ml. Cycle conditions:
(928C 2min), 928C1 0s ,5 5 8C3 0s ,6 8 8C 24min; 20 cycles.
Mammalian cell lines and transfections
Normal Human Astrocytes (NHA cells) from Cambrex
was cultured in Astrocyte Basal Medium (Cambrex)
added AGM SingleQuots (Cambrex). Other cell lines
were cultured in D-MEM growth media (GIBCO)
containing 10% heat-treated fetal calf serum, penicillin
(1.2g/l) and streptomycin (2.0g/l) in 75cm
2 ﬂasks.
Twenty-four hours before transfection cells were seeded
into 6-well plates. Transfections were conducted with 1 mg
DNA using FuGene 6 Transfection Reagent (Roche).
Co-transfections of the GFAP wt minigene and the SR
protein encoding plasmids were performed with 1mgo f
each, and co-transfections of the GFAP wt minigene and
VP16 were conducted with 1mg GFAP minigene and
0.1mg VP16 plasmid.
N2A cells were highly reproducible transfected and for
this cause used in most of the experimental examinations.
A172 and the primary astrocyte cells express endogenous
GFAP and were used in experiments addressing the
importance of regulatory mutants and trans-factors also
in more biological relevant cellular systems. We note a
day-to-day variation of the GFAP transcript ratios, and in
the E7pA/E9pA ratio, in the order of 2-fold which could
be caused by diﬀerent cellular conditions.
Chemical treatments of cells
Actinomycin D (10mg/ml), BAPTA (100mM) and CdCl2
(100mM) (all from Sigma) treatment was started 48h post
transfection, heat-shock of cells was started 24h post
transfection, and after the indicated periods of time
cells were harvested in Tri Reagent (Sigma) and frozen
in –808C before extraction of RNA.
RNA extraction and cDNA synthesis
Forty-eight hours post transfection total RNA was
extracted using Tri Reagent and stored at  808C. cDNA
was synthesized from 1g total RNA in 20l reactions
using iScript
TM cDNA synthesis Kit (Biorad). After
synthesis, the cDNA was diluted ﬁve times with double-
distilled water and stored at 48C.
Quantitative real-time PCR
Quantitative real-time PCR was performed on an iCycler
Thermal Cycler (Bio-Rad) using the iCycler iQ
TM
Real-time PCR Detection System (Bio-Rad). All reactions
were performed in triplicates in a total volume of 20ml
each using DyNAmoTM HS SYBR GREEN qPCR Kit
(Finnzymes). Two micro litres cDNA was used as
template and 6pmol of each primer (sequences in
Table 1). Primer eﬃciency was measured by dilution
standard curves (above 95%). The amount of mRNA was
normalized to the measured expression of glyceraldehyde
3-phosphate dehydrogenase (GAPDH) mRNA in each
sample and the quantiﬁcation was done using the 2
–C
T
method (32). For quantiﬁcation of mRNA expression
from the minigenes forward primer pTAG4E1E2 was used
for GFAPa, GFAPe and GFAPk, and reverse primers
were hsGFAPE9r, hsGFAPE7Ar and hsGFAPI7r,
respectively. For quantiﬁcation of pig GFAP mRNA
forward primer GFAPE6f was used for GFAPa, GFAPe
and GFAPk and reverse pigGFAPE9r, pigGFAPE7Ar
and pigGFAPI7r, respectively. After each assay, the
identity of the PCR products was conﬁrmed by melting-
curve analysis and gel electrophoresis.
Rapid amplification of cDNA 3’ ends(3’-RACE)
First-strand cDNA synthesis was synthesised from 3mg
total RNA using SuperScript
TM II Reverse Transcriptase
(Invitrogen) with 50pmol of a modiﬁed oligo d(T) primer
oligo(dT)V. RT–PCR was conducted using 5ml cDNA,
5U Taq DNA polymerase and 20pmol of each primer.
For the RT–PCR was used the reverse primer Oligo(dT)r
tagging the oligo(dT)V primer and the forward primer
pTAG4E1E2. PCR conditions: 958C3 0 s ,5 8 8C 1min,
728C 3min, 30 repeats. Nested PCR was conducted using
5ml of the RT–PCR reaction as template under the
conditions described above using reverse primer
Oligo(dT)r and forward primer GFAP5242f. PCR
products were separated with gel electrophoresis in
1% agarose, extracted and sequenced using DYEnamic
ET terminator Cycle Sequencing Kit (Amersham
Biotech Inc.).
RT–PCR
cDNA synthesized from A172 cells transiently transfected
with either the GFAP wt, the GFAP30ss or
GFAPmE7pA minigenes were used as template.
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isoforms and reverse primers hsGFAPE9r, hsGFAPE7Ar
and hsGFAPI7r for GFAPa, GFAPe and GFAPk,
respectively. For possible reading trough of the poly(A)
signal in exon 7a, primer GFAP6061r was used. As a
positive control, 20ng plasmid DNA was ampliﬁed by
primers GFAP5242f and GFAP6061r. For PCR the
Phusion High Fidelity DNA polymerase was used at the
cycle conditions: 988C1 0s ,7 1 8C3 0s ,7 2 8C 45s; 36 cycles.
PCR products were separated in a 1.2% agarose gel.
siRNA-mediated gene knockdown
Twenty-four hours before transfection, Hek293 cells
were seeded into 6-well plates, at an amount of 1 10
5
cells per well. The cells were grown in RPMI growth
medium (GIBCO) added 10% fetal calf serum, penicillin
(1.2g/l) and streptomycin (2.0g/l), but during transfection
cells were grown without antibiotics. Forty-ﬁve picomoles
of siRNA (Dharmacon) was transfected into the
cells using siLentFect (Biorad). Forty-eight hours after
transfection the media was replaced with fresh medium,
and 1h after cells were transfected a second time, with
either the GFAPmE7p(A) minigene alone or together
with siRNA directed against Rrp6 or an irrelevant
target as control, using Lipofectamine 2000 (Invitrogen).
The cells were harvested after another 48h. Five micro-
grams total RNA was treated with DNase (Turbo
DNA-free kit, Ambion). cDNA was synthesized from
0.5mg DNase treated RNA in 20m reactions using
iScript
TM cDNA synthesis Kit. After synthesis, the
cDNA was diluted ﬁve times with double-distilled
water and stored at 48C. The RT–PCR was conducted
as above, using identical primers, but the PCR only for 30
repeats.
Western blot
Forty-eight hours after the second transfection the
medium was removed from the Hek293 cells and they
were washed with PBS twice. The cells were scraped of
the well in 1ml PBS and aliquot into two eppendorf
tubes, one for extraction of RNA and one for protein,
and centrifuged 3min at 1200g. Cells were washed with
PBS and centrifuged 10s at 14000g and stored at –808C.
Cells were harvested in 200ml lysis buﬀer (Tris–HCl
50mM, EDTA 10mM, SDS 1%) added one Complete
Protease Inhibitor Cocktail tablet (Roche) by alternate
freezing in dry ice and thawing in 378C three times,
incubated on ice for 30min and centrifuged at 14000g
for 10min. The supernatant was removed and the
protein concentration was measured by Bradford. Four
micrograms protein was added 5 Loading Buﬀer
(Fermentas), 20  Reducing Agent (Fermentas) and PBS
to a ﬁnal volume of 15mla n da1   concentration, and
the samples were heated to 1008C for 5min. Western
blotting analysis were performed at standard conditions
and visualized by BM Chemiluminescence (Roche).
The primary antibodies against Rrp6 (PM/Scl100, Ger
Pruijn) and hnRNPC1/C2 (4F4 from Seraﬁn Pinol-Roma)
were diluted 1:4000 and 1:5000, respectively.
RESULTS
Establishment ofaGFAP minigene
A map of the GFAP gene, the mRNA types and
the corresponding proteins addressed in this study is
shown in Figure 1A. GFAPa represents the most common
isoform. GFAPe and GFAPd are distinguishable only
at the RNA level. To generate the GFAPe mRNA is used
the exon 7a polyadenylation (E7pA) signal (6), whereas
GFAPd mRNA includes exon 7d, exon 8 and exon 9 (5).
GFAPk mRNA is generated in the absence of intron
7a splicing and simultaneous use of the E7pA signal.
A putative novel GFAP mRNA, GFAPf, was deduced
and generated when intron 7a splicing and E7pA signal
use were absent. The expression pattern of the GFAPa,
GFAPe and GFAPk mRNAs has previously been
described in brain samples and derived cell cultures (9).
To characterize the splicing events involved in
alternative 30-end formation of GFAP mRNA, we created
a minigene including the 30-part of the human GFAP
gene inserted into the pTAG4 expression vector. GFAP
sequences from intron 6 to position 291 after the exon 9
polyadenylation (E9pA) signal were fused to exons 1 and 2
from the human adenovirus 2 under control of the SV40
enhancer and promoter region (Figure 1B). The GFAP
minigene was transfected into several diﬀerent cell
lines, and cDNA was examined for the presence of
various GFAP mRNAs. GFAPa, GFAPe and GFAPk
mRNA were readily detectable whereas GFAPd and
GFAPf mRNA were undetectable (Figure 1C and data
not shown). Other types of putative GFAP mRNAs
were not detected (data not shown). Accordingly, the
types of GFAP mRNAs expressed from the GFAP
minigene resemble what was previously observed for
endogenous GFAP in brain samples and derived cell
cultures (9).
For a precise determination of the ratio between the
three types of detectable GFAP mRNAs expressed
from the minigene we performed a quantitative real-time
RT–PCR analysis. A common forward primer was used
together with reverse primers detecting each of the three
examined GFAP mRNA types with resulting RT–PCR
products in the size of 200bp. The reverse primer for
GFAPa mRNA detection is located in exon 9, the primer
for GFAPe mRNA detection in exon 7a and the primer
for GFAPk mRNA detection in intron 7a which
is included as an exon in the GFAPk transcript. The
RT–PCR assays were designed to span intron sequences
to eliminate the contribution of contaminating DNA.
Note that since the GFAPk mRNA is 354bp longer
than the GFAPe mRNA, due to the inclusion of the
intron 7a sequence in GFAPk, the PCR reactions used for
detecting GFAPe mRNA would in principle also detect
GFAPk mRNA. To eliminate this possibility the assay
was run with a PCR extension time not allowing
co-ampliﬁcation of mRNA representing GFAPk. The
speciﬁcity of each PCR reaction for ampliﬁcation of only
one type of GFAP mRNA was veriﬁed by melting
curve analysis and gel electrophoresis of the PCR products
after each reaction (data not shown). Data is presented
as expressed mRNA ratios since such values were
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which varied experimentally. The GFAPe/GFAPk
mRNA ratio represents an estimate of exon 7a splicing
eﬃciency. For a measure of the frequency of the two
possible polyadenylation events possible for the GFAP
transcripts we made the approximation that the
ratio between transcripts terminating at the exon 7a
polyadenylation signal and the exon 9 polyadenylation
signal, E7pA/E9pA, was similar to the mRNA ratio
(GFAPe+GFAPk)/GFAPa. This is an acceptable
approximation because GFAPa, GFAPe and GFAPk
were the only GFAP transcripts detectable from the
minigene.
In transfected A172 human glioblastoma cells, GFAPa
and GFAPe mRNAs were expressed to an equal ratio
whereas GFAPk mRNA was expressed at a 5- to 15-fold
lower level (Figure 1D). Similar ratios of expression
were observed in HeLa and HEK293T cells. In mouse
N2A cells, the three GFAP mRNAs were expressed
close to an equal level and in human NHA primary
astrocytes and rat primary astrocytes GFAPa mRNA was
expressed at the highest level (Figure 1D). Transfection
titration experiments varying the concentration of
the minigene in the transfections from 10ng to 2mg did
not signiﬁcantly inﬂuence the relative level of expression
for the GFAP mRNAs (data not shown). We note a
day-to-day variation, within a 2-fold range, of the GFAP
transcript ratios and in the E7pA/E9PA ratio in the
cellular transfection experiments presented.
In brain samples, endogenous GFAPa mRNA is
expressed at a higher level than the GFAPe and
GFAPk mRNA (9). To examine if the GFAP minigene
lacked the sequences required for enhancement of GFAPa
mRNA expression we ﬁrst examined the consequence
of additional sequences after the polyadenylation
sequence in exon 9. Inclusion of additional 1828bp did
not inﬂuence the expression ratio for the GFAP mRNAs
(Figure 1E). We note that addition of this sequence
extended the 30-region of the GFAP gene to the position
of the last exon of the neighbouring gene, coiled-coil
domain containing 103, on chromosome 17 and may
thereby include all intrinsic sequences required for GFAP
E9pA signal usage.
The GFAP minigene contained no open reading frames.
By site-directed mutagenesis we introduced a Kozak
translational initiator sequence in exon 1. From this
methionine an open reading frame extended into the
GFAP part of the minigene in the frame normally used
for the GFAP gene. The expression of the GFAPe
C-terminal protein sequence from the GFAP-ATG mini-
gene construct was veriﬁed by western blotting (data
not shown). Introducing the open reading frame did
not result in any signiﬁcant variation of GFAP mRNA
ratios (Figure 1E). We therefore conclude that translation
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Figure 1. Construction and functional analysis of a GFAP minigene.
(A) A schematic picture of the GFAP gene structure. The
grey boxes denote the exons and the black horizontal lines the introns.
Below is shown the arrangement of the exons in the GFAPa, GFAPe,
GFAPk, GFAPd and GFAP mRNA. The positions of stop codons are
indicated by asterisks. (B) A schematic picture of the GFAP wt minigene.
GFAP gene sequences from intron 6 through exon 9 were inserted into the
pTAG4 vector. The vector contains the SV40 promoter and two internal
exons (marked 1 and 2) and lacks internal poly(A) signals. The positions
of the reverse primers used for real time PCR are denoted as black arrows:
primers in intron 7a, exon 7a, intron 7 and exon 9 for ampliﬁcation of
GFAPk, GFAPe, GFAPd and GFAP, and GFAPa, respectively. The
forward PCR primer was spanning exon 1 and 2. (C) Gel electrophoresis
of the PCR products from real-time PCR with the primers shown in (B).
GFAPa (266bp), GFAPe (299bp) and GFAPk (296bp) are expressed
from the GFAP wt minigene. Since the GFAPk mRNA is 354bp longer
thanthe GFAPemRNA, only GFAPe isampliﬁed bythe primer placedin
exon 7a, at the used experimental conditions. (D) The expressed ratios of
GFAPa/GFAPe, GFAPa/GFAPk and GFAPe/GFAPk mRNA in
normal human astrocytes (NHA cells), primary rat astrocytes (PRA),
A172, HeLa, N2A and HEK293T cells transiently transfected with the
GFAP wt minigene. The SDs from three independent assays are shown.
The E7pA/E9pA ratios are also shown. (E) The expressed ratios of
GFAPa/GFAPe, GFAPa/GFAPk and GFAPe/GFAPk mRNA, as well
as the E7pA/E9pA ratios, in A172 cells transiently transfected with the
GFAP wt, the GFAP+ATG (coding) or the GFAP+1828bp minigenes.
The E7pA/E9pA ratios are also shown.
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mRNAs generated from the minigene.
The GFAP transcripts from the minigene were
examined for their stability by a pulse-chase experiment
as previously described (33). RNA polymerase II
transcription was arrested by adding actinomycin-D to
transfected N2A cells, and the amounts of GFAP mRNA
present after 1, 4 and 6h were measured by real-time PCR
(Figure 2). Control cells were treated with the solvent of
actinomycin-D, DMSO. Compared to the DMSO control
the actinomycin-D treatment resulted in a 2-fold increase
in the GFAPa/GFAPk and GFAPe/GFAPk mRNA
ratios consistent with a preferential decrease in the
amount of GFAPk mRNA (Figure 2 and data not
shown). However, if this decrease was due to an altered
stability of the GFAPk mRNA, the change in mRNA
ratio would be expected to increase with time. This was
not observed (Figure 2). We also noted that the GFAP
mRNA ratios after actinomycin-D treatment resembled
the proﬁle normally present in N2A cells transfected with
the GFAP minigene (Figure 2). Thus, the experiment
indicates a similar mRNA stability for all three GFAP
transcripts. The eﬀect on the GFAPk mRNA level seemed
instead to be caused by the DMSO eﬀect itself on the cells.
We noted that treatment of the N2A cells with DMSO for
longer timescales than the ones presented resulted not only
in morphological cell changes but also in a decrease in the
GFAPk mRNA amounts in the actinomycin-D-treated
cells (data not shown).
The cellular environment aﬀects both the expression of
the GFAP gene and the GFAP ﬁlament structure (1).
Ca
2+ is an example of a mediator for GFAP ﬁlament
reorganization, and in addition Ca
2+ levels can aﬀect
alternative splicing events. Accordingly, we considered
whether the GFAP mRNA splicing and polyadenylation
ratios could be aﬀected by intracellular Ca
2+ levels. By
adding the cell permeable Ca
2+ chelator BAPTA (34) a
decrease in the GFAPa/GFAPe and GFAPa/GFAPk
ratios was observed together with an increase in the
E7pA/E9pA ratio (Figure 3A). Thus, BAPTA treatment
appears to aﬀect the GFAP gene polyadenylation signal
selection. We also addressed the importance of Ca
2+ inﬂux
by using Cd
2+ to block the inﬂux of extracellular Ca
2+
through voltage dependent Ca
2+ channels (34). No
signiﬁcant alteration in the ratio of polyadenylation
signal selection was detected (Figure 3B).
Thermal stress is a physiological stress which may result
in the turning on of heat shock response genes and
reorganization of the cytoskeleton including GFAP
ﬁlament reorganization. Altered GFAP expression is
also observed after terminal stress. To further monitor
the importance of terminal stress for the ratio of the
E7pA/E9pA
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Figure 2. Determination of the relative GFAP mRNA stabilities. N2A cells transfected with the GFAP minigene were 48h after transfection
added actinomycin-D or as control the vehicle solution DMSO for the indicated time points. RNA was extracted and real-time RT–PCR was used
to determine the ratios of GFAPa/GFAPe mRNA, GFAPa/GFAPk mRNA and GFAPe/GFAPk mRNA, as well as the E7pA/E9pA ratio.
The labelling H2O indicates transfected N2A cells not treated with DMSO and actinomycin-D.
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Figure 3. Environmental conditions aﬀect GFAP polyadenylation
signal selection. (A) N2A cells transfected with the GFAP minigene
were added BAPTA or as control the vehicle solution NaHCO3. RNA
was extracted and real-time RT–PCR was used to determine the
ratios of GFAPa/GFAPe mRNA, GFAPa/GFAPk mRNA and
GFAPe/GFAPk mRNA, as well as the E7pA/E9pA ratio. (B)A si n
(A) except for the addition of CdCl2 or as control H2O. (C) Transfected
N2A cells were 24h after transfection incubated at 428C for the
indicated time points. RNA was analysed by real-time RT–PCR as
described in (A).
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Figure 4. Exon 7a polyadenylation is required for alternative GFAP 30-end processing. (A) The sequence of the polyadenylation signal in exon 7a
with the AAUAAA hexamer and the AUUAAA hexamer (underlined). The position of poly(A) tail additions with origin from the polyadenylation
signals were identiﬁed by 30-RACE experiments and are marked with underscore. The G-rich region downstream the poly(A) signal compositing the
PRE motif is shown in italic and bold. This region together with ﬂanking sequences was deleted in the dPRE minigene. The position of the examined
SNP is double underlined. The position of the intron 7a/exon 7a border is marked by a slash. (B) A172 cells were transiently transfected with the
GFAP wt, GFAP-mE7pA (mutation of the exon 7a polyadenylation signal) or the GFAP-mE9pA (mutation of the exon 9 polyadenylation signal)
minigenes. The expressed ratios were quantiﬁed by real-time PCR. (C) Gel electrophoresis of RT–PCR performed with cDNA made of total RNA
extracted from A172 cells transiently transfected with either the GFAP wt minigene (wt) or GFAP-mE7pA. GFAPa (266bp) and GFAPe (299bp)
are detected in (wt) and GFAP-mE7pA transfected cells. Note that the primers for GFAPe in this experimental setting also amplify cDNA
representing GFAPk (653bp) (indicated by arrow). Neither GFAPd nor GFAP expression could be detected (expected sizes of 951 and 1305bp,
respectively). Plasmid DNA is used as a positive control for the reverse primer used for GFAP ampliﬁcation (lane C). The position of the reverse
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experiment using N2A cells transfected with the GFAP
minigene. As observed for the BAPTA treatment the
GFAPa/GFAP  and GFAPa/GFAPk ratios decreased
together with an increase in the E7pA/E9pA ratio
(Figure 3C). Thus, also terminal stress seems to aﬀect
the selection of GFAP polyadenylation sites.
Characterization of theregulation of exon7a
polyadenylation signal selection
To address the function of alternative polyadenylation for
GFAP 30-end formation, we ﬁrst analysed minigenes with
mutations in the E7pA and E9pA signals (see legend to
Figure 4A). Mutation of the E9pA signal decreased as
expected both the absolute amount of GFAPa mRNA as
well as its relative level to the other GFAP mRNAs
(Figure 4B and data not shown). No eﬀect was observed
on the GFAP /GFAPk mRNA ratio. Mutation of the
E7pA signal resulted in an increased amount of GFAPa
mRNA, and only residual amounts of GFAP  and
GFAPk mRNA could be detected (Figure 4B and data
not shown). This was also observed in primary human and
rat astrocytes (data not shown). Due to the low level of
both GFAP  and GFAPk mRNA, calculations of
expression ratios are connected with signiﬁcant uncertain-
ties but no gross alteration in the GFAP /GFAPk mRNA
ratio was observed. Next, we addressed the molecular
origin of the residual GFAP  mRNA and GFAPk mRNA
by 30-RACE experiments. GFAP  and GFAP  mRNA
expressed from the wt minigene were identiﬁed to be
polyadenylated using the expected consensus polyadeny-
lation signal AAUAAA. From the minigene with a
mutation in the E7pA signal the GFAP  and GFAPk
mRNA bands represented cDNA polyadenylated by
usage of another polyadenylation signal in exon 7a with
weaker consensus AUUAAA (motif localization is shown
in Figure 4A). Polyadenylation events originating from
this new signal were observed only in the presence of the
mutation within the E7pA signal. To further substantiate
the observed dependence of exon 7a polyadenylation for
generation of the GFAP  and GFAPk mRNAs, we
addressed the question if mutating the E7pA signal
could result in inclusion of downstream sequences as
new exonic sequences in the mRNA and thereby generate
the GFAPd or GFAPf mRNAs. RT–PCR analysis with
reverse primers located downstream of the E7pA signal
sequence revealed complete absence of cDNA represent-
ing GFAPd or GFAPf (data not shown and Figure 4C).
The lack of detectable GFAPd or GFAPf mRNA could
be a consequence of the cellular recognition of these
mRNAs as aberrant. To address this possibility, we used
RNAi to deplete cells for the mRNA degrading nuclear
exosome component Rrp6 and examined GFAP mRNA
expression from the normal minigene and the minigene
with the E7pA signal mutation (Figure 4D and E). Rrp6
depletion resulted neither in the presence GFAPd or
GFAPf mRNAs nor in a signiﬁcant increase of GFAPa,
GFAPe or GFAPk mRNA (Figure 4E and data not
shown). Thus, the absence of mRNA including sequences
downstream of the E7pA signal is most likely not
explained by nuclear mRNA degradation but rather by
splicing out of the entire intron 7. Together, these data
indicate that usage of E7pA is essential for the quantita-
tive generation of the GFAPe and GFAPk mRNAs, and
that absence of the functional E7pA signal does not
produce GFAPd or GFAPf mRNA. Accordingly, GFAP
30-end alternative processing is dependent on a functional
alternative polyadenylation site.
Given the regulatory importance of the E7pA site we
searched for cis-sequences participating in this regulation.
In the GFAP exon 7a, a G-rich sequence containing the
motif, GGGGGGGGGGG, is located 90bp downstream
of the polyadenylation site. G-rich sequences have
previously been shown to participate in enhancement of
polyadenylation (35–37). The eﬀect of deletion of this
putative polyadenylation regulatory element (PRE) was
examined in the context of the minigene. Complete
PRE deletion resulted in a 2-fold increase in the
GFAPa/GFAPe mRNA and GFAPa/GFAPk mRNA
ratios in primary rat astrocytes, and a corresponding
decrease of the E7pA/E9pA ratio (Figure 4F). This eﬀect
was also observed in other cell lines (data not shown).
Thus, the PRE is a candidate element for stimulation of
E7pA usage. Interestingly, an SNP (A/G) at position 6 in
the PRE motif (underlined above) is present in the human
population. An A at position 6 in the PRE generates a
MAZ protein-binding consensus, a site previously identi-
ﬁed to be involved in RNA polymerase II pausing,
transcriptional termination, and activation of polyadeny-
lation (38–41). The frequency of the A and G alleles are
0.81 and 0.19, respectively, in the human Caucasian
population (data not shown). The GFAP minigene used in
our analysis has a G in the PRE, and by mutagenesis a
minigene with A in the PRE was constructed. The eﬀect of
this change was analysed in a number of cell lines and no
detectable alteration in the ratio between the diﬀerent
GFAP mRNAs was observed (Figure 4G and data not
shown). We conclude that the PRE motif supports exon
7a polyadenylation independent of the PRE SNP
sequence.
primers is schematically shown in Figure 1B. (D) Western blot of protein extracted from HEK293T cells transfected with either the GFAP-mE7pA
minigene alone, or together with siRNAs against Rrp6 (siRrp6) or an unspeciﬁc siRNA (SiC) as control. To the left the marker sizes are shown.
Expression of Rrp6 (100kDa) is detected with a monoclonal antibody and as loading control the expression of hnRNPC1/C2 is shown (33kDa).
(E) RT–PCR of RNA extracted from the transfected HEK293T cells in (D). GFAPa and GFAPe and are detected as fragments of 266 and 299bp,
respectively. Neither GFAPd nor GFAP are detected (expected sizes of 951bp and 1305bp, respectively), in wt, GFAP-mE7pA, or GFAP-mE7pA
and siRrp6 transfected cells. Plasmid DNA is used as a positive control for the reverse primer used for GFAP ampliﬁcation (lane C). The position
of the reverse primers is schematically shown in Figure 1B. (F) Cis-elements inﬂuence alternative GFAP polyadenylation signal selection. Primary rat
astrocytic cells were transiently transfected with either GFAP wt or GFAP-dPRE (deleted PRE sequence) minigenes. The expression ratios were
quantiﬁed by real-time RT–PCR as previously described. (G) A minigene with nucleotide A in the SNP position 6 in the PRE motif was examined
together with the wt minigene as in (F). Note the wt minigene contains a G nucleotide in the PRE SNP.
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alternative GFAP 3’-endformation
We next addressed determinants for the regulation of the
GFAP mRNA ratios. For these experiments, the N2A
neuroblastoma cell line was used as we have observed
highly reproducible transfection eﬃciency in this cell line.
First, we examined the importance of the intron 7a
30-splice site (for sequence see Figure 5A). A mutation
within the splice site consensus CAG/G to ATT/T
abolished, as expected, the generation of GFAPe mRNA
(data not shown). Also the amount of transcripts
terminated by the E7pA signal decreased indicating
that the absence of the splice site, and thereby GFAPe
mRNA production, did not result in a proportional
increase in the amount of GFAPk mRNA (Figure 5B).
This further suggested a link between the use of
the intron 7a 30-splice site and the polyadenylation
site. The GFAPa/GFAPk mRNA ratio was increased
to an expected degree if instead of GFAPe mRNA a
proportional amount of GFAPa mRNA was generated
(Figure 5B).
Alignment of the intron 7a 30-splice site sequence with
an optimal consensus splice site sequence revealed the
presence of a putative optimal branch point sequence but
also the presence of several purines within the sequence
which is optimally composed of polypyrimidines
(Figure 5A). A minigene was constructed with an optimal
polypyrimidine tract, and expression analysis showed that
this mutation increases the amount of GFAPe mRNA
both at the absolute level (data not shown) and relative to
GFAPa and GFAPk mRNAs (Figure 5B). The absolute
amount of GFAPk mRNA and the GFAPa/GFAPk
mRNA ratio did not decrease proportionally indicating
that the total amount of mRNA generated from E7pA
signal usage was increased (Figure 5B and data not
shown). In accordance, the E7pA/E9pA ratio increased
(Figure 5B). We note that even in the presence of the
optimized polypyrimidine tract at the intron 7a 30-splice
site signiﬁcant splicing from exon 7 to exon 8, which
excludes exon 7a, does take place (Figure 5B).
In conclusion, the composition of the GFAP intron 7a
30-splice site is a limiting factor for exon 7a inclusion and
polyadenylation, but clearly not the only determinant for
transcriptional termination at the E7pA signal and exon
7a inclusion in the mature transcript. Even in the presence
of an optimized intron 7a 30-splice site, transcriptional
read through of the E7pA signal and splicing out of the
entire GFAP intron 7 was observed. This suggests that the
recognition/utilization of the E7pA signal is also an
important determinant for GFAP 30-end formation.
Imperfect consensus splice sites are often supported
by the presence of neighbouring splice-enhancing
cis-sequences, and we searched for such sequences in
silico by ESEﬁnder [(42) release 2.0 http://rulai.cshl.edu].
Within the ﬁrst part of exon 7a three high-scoring
putative splice enhancers (ESEs) were present
(Figure 6A). All three ESE elements constituted putative
SF2/ASF-binding sites. In addition, the ESE2 element is
an SRp40-binding site and the ESE3 element an SRp40
and a SC35-binding site. Nucleotide substituting muta-
tions were introduced in these sequences individually, and
the eﬀect on GFAP mRNA expression examined. In N2A
cells, each of the mutations decreased the GFAPe/
GFAPk mRNA ratio indicating that all three ESE
sequences possess splice enhancer activity (Figure 6B).
Splice-enhancer activity was observed also in A172 cells,
primary human astrocytes and primary rat astrocytes, but
in these cell lines the eﬀect of ESE2 was minimal
(Figure 6C and data not shown). Introduction of a
double mutation in ESE1 and ESE3 had no additive eﬀect
compared to the individual mutations (Figure 6B, 6C, and
data not shown). In N2A cells, the ESE mutations have
onlyamarginaleﬀectontheE7pA/E9pAratio(Figure6B).
In A172 cells, the ESE3 mutation resulted in a decreased
E7pA/E9pA ratio supporting the fact that ESE sequences
participate in E7pA signal selection (Figure 6C).
As the function of splice enhancers could be restricted
to the presence of a weak 30-splice sequence we examined
the eﬀect of the ESE1/ESE3 double mutant in combina-
tion with the optimized polypyrimidine tract at the
30-splice site. Surprisingly, the ESE1/ESE3 double muta-
tion completely abolished the gain mediated by the
optimized polypyrimidine tract mutation for the
GFAPe/GFAPk mRNA ratios and E7pA/E9pA ratios
(Figure 6D). Also, the decreased GFAPa/GFAPe mRNA
ratio resulting from an optimized polypyrimidine tract
was reverted by the combined mutation (Figure 6D), and,
interestingly, the GFAPa/GFAPk mRNA ratio increased
(Figure 6D). This indicates that optimization of the
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Figure 5. Exon 7a polyadenylation requires a functional 50-splice site.
(A) An overview of the pyrimidine tract preceding the 50-splice site
of exon 7a. The branch point consensus is shown to the left, and
the consensus sequence of the ‘ideal’ pyrimidine tract is shown beneath
the exon 7a sequence. Below, the sequence of the mutated, optimized
sequence is shown. (B) The expressed ratios of GFAPa/GFAPe,
GFAPa/GFAPk and GFAPe/GFAPk, together with the E7pA/E9pA
ratio, in N2A cells transiently transfected with the GFAP wt,
GFAP-d3’ss gene with a mutated intron 7a 30-splice site, or the
GFAP-Y minigene with an optimized polypyrimidine tract in the intron
7a 30-splice site.
7644 Nucleic Acids Research, 2007, Vol. 35, No. 22polypyrimidine tract alone is not suﬃcient, and still
requires support from the ESE motifs to stimulate exon
7a inclusion and polyadenylation signal selection.
Overexpression of SR proteins stimulates
alternative polyadenylation
Limitations of the amount of speciﬁc polyadenylation
trans-factors have previously been shown to be important
in the regulation of alternative polyadenylation signal
selection. At ﬁrst, we asked whether non-SR protein trans-
factors, which in other regulatory systems inﬂuence
polyadenylation signal selection, could also have an
eﬀect on GFAP E7pA selection. To this end, we cloned
several of these factors and co-expressed them in A172
astrocytes together with the GFAP minigene. Expression
of protein was veriﬁed by western blotting (data not
shown). Note that such factors also have a potential to
participate in the regulation of splicing. hnRNPH1,
hnRNPF and CstF-64 had no eﬀect on the ratio between
the diﬀerent GFAP mRNAs or on the absolute expression
level of the individual mRNAs. PTB had a negative
inﬂuence on the expression of GFAPa mRNA and
accordingly resulted in decreased GFAPa/GFAPe
and GFAPa/GFAPk mRNA ratios and an increased
E7pA/E9pA ratio (data not shown and Figure 7A). No
signiﬁcant alteration in the GFAPe/GFAPk mRNA ratio
was observed. Thus, PTB overexpression supports E7pA
signal usage and a proportionally increased usage of the
intron 7a 30-splice site and accordingly proportional
coupling of these events. Ectopic hnRNPH2 expression
resulted in a relative increase in GFAPk mRNA
A
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Figure 6. Exon 7a splicing and polyadenylation is regulated by SR proteins and exon splice enhancer, ESE, sequences. (A) The sequence of the
50-part of exon 7a. The three putative ESEs are underlined. In order to test their functionality they were mutated either individually or in
combination to produce the minigenes ESE1, ESE2, ESE3 and ESE1/3, respectively. (B) The expressed ratios of GFAPa/GFAPe, GFAPa/GFAPk
and GFAPe/GFAPk, and the E7pA/E9pA ratio, in N2A cells transiently transfected with the GFAP wt or the ESE1, ESE2, ESE3 and ESE1/3
minigenes. (C) As (B) but with transfections in A172 cells. (D) The expressed ratios in N2A cells transiently transfected with the GFAP wt, GFAP-Y
or the GFAP-Y-ESE1/3 combined mutation.
Nucleic Acids Research, 2007, Vol. 35, No. 22 7645compared to the other two types of mRNA (Figure 7A).
We have previously shown that the GFAPa/GFAPk and
GFAPe/GFAPk mRNA ratios increased during cortex
ageing (9). To examine if the expression pattern of PTB
and hnRNPH2 followed the pattern of GFAP mRNA
ratios we examined the expression level during cortex
ageing. Both factors had a signiﬁcantly altered expression
at the examined time points but a correlation to GFAP
mRNA expression patterns was not evident (data not
shown).
We then examined how GFAP expression responded
to co-transfection with expression vectors for diﬀerent
SR proteins. An increase in the amount of speciﬁcal
GFAPk mRNA was consistently observed in transfected
A172 cells (Figure 7B and data not shown). The decrease
in the GFAPe/GFAPk mRNA ratio does not
support that ectopic expression of SR protein stimulated
the usage of the intron 7a 30-splice site. By contrast,
the E7pA/E9pA ratio was increased by SR protein
overexpression (Figure 7B). This eﬀect was not a general
eﬀect by overexpression of RNA-binding proteins as
for example overexpression of hnRNPF not showed
the same eﬀect (Figure 7B). Titration analysis using
from 10ng to 1mg of expression vector for SR protein
resulted in the similar tendency for GFAP mRNA
expression ratios (data not shown). Thus, SR protein
overexpression stimulated E7pA signal selection, and this
stimulation was not followed proportionally by intron 7a
30-splice site usage.
Promoter activity influencesGFAP 3’-endformation
Promoter controlled transcriptional initiation and elonga-
tion eﬃciency has previously been shown to inﬂuence
the degree of alternative splicing (43,44). To address the
importance of a speciﬁc promoter composition for
the ratio between the diﬀerent GFAP mRNAs we inserted
the native GFAP promoter instead of the SV40 promoter
in the context of the minigene. The GFAP promoter is
speciﬁcally active in cells of astrocytic lineages.
Comparison of the GFAP promoter minigene with the
SV40 promoter minigene showed that the expression ratio
between the diﬀerent GFAP mRNAs was similar for the
two constructs both in human and in rat primary
astrocytes (Figure 8A and B and data not shown). We
note that also the absolute expression levels of the GFAP
mRNAs from the SV40 promoter and GFAP promoter
minigenes were similar (data not shown). Introduction of
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Figure 7. Trans-factors inﬂuence alternative GFAP polyadenylation
signal selection. (A) Co-expression of the GFAP wt minigene and trans-
factors involved in polyadenylation signal selection. A172 cells were
transiently transfected with either the GFAP wt minigene and an empty
vector or the GFAP wt minigene and a vector containing the open
reading frame of factors determined to be involved in alternative
polyadenylation. The GFAP mRNA ratios were quantiﬁed by real-time
PCR. C indicates the control experiment in where the GFAPwt
minigene was cotransfected with empty expression vector. (B) The
GFAP mRNA ratios were determined in A172 cells transiently
transfected with GFAP wt together with plasmids encoding the SR
proteins ASF/SF2, SC35, Srp40, 9G8 or Srp55. C indicates the control
experiment in where the GFAPwt minigene was cotransfected with
empty expression vector. As a control RNA binding protein was
included a transfection with an hnRNPF expression vector which in (A)
was shown to have no eﬀect on the expression ratios. The expressed
ratios were quantiﬁed by real-time PCR.
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Figure 8. Promoter activity inﬂuences alternative GFAP 30-end proces-
sing. (A and B) The SV40 promoter in the GFAP wt minigene was
switched with the endogenous GFAP promoter and transiently
transfected into NHA cells (A) or primary rat astrocytes (B).
The indicated expressed ratios were quantiﬁed by real-time PCR.
(C) The SV40 promoter in the GFAP wt minigene was switched with
the b-globin minimal promoter or the tk minimal promoter with
additional two upstream GAL4 recognition sites. The minigenes were
transiently transfected into N2A cells co-transfected with the chimerical
transcription factor GAL4-VP16. The expressed ratios were
quantiﬁed by real-time PCR. Note that for illustration purposes the
GFAPk/GFAPe ratio is shown in this particular ﬁgure.
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within the background of the GFAP promoter minigene
also showed similar results as observed for the SV40
promoter driven minigene (data not shown).
To further monitor the importance of transcriptional
activity for GFAP 30-end formation we generated a series
of minigenes under control of promoters inducible by the
chimerical GAL4-VP16 transcription factor. Two GAL4-
binding sites were introduced in either the b-globin or the
thymidine kinase (tk) gene promoters in context of the
minigene. The GFAP E7pA/E9pA ratios were diﬀerent
from the tk and b-globin promoter controlled minigenes
as compared to the SV40 promoter controlled minigene
indicating that diﬀerent promoters may inﬂuence poly-
adenylation signal selection ratio (Figure 8C). We noted
that the tk and b-globin minigenes had less basal promoter
activity than for the SV40 minigene as the absolute GFAP
mRNA expression levels were 10–15-fold lower (data not
shown). GAL4-VP16 was previously shown to regulate
alternative splicing by stimulating both transcriptional
initiation and elongation (43,45,46). The minigene under
control of the SV40 promoter was not aﬀected by GAL4-
VP16 co-expression as expected from the lack of GAL4
recognition motifs within the promoter. For the minigene
under control of the b-globin promoter and two GAL4
recognition motifs GAL4-VP16 increased the absolute
amount of GFAPa mRNA  8-fold and for the tk
promoter minigene 15-fold (data not shown). All three
GFAP mRNAs had increased expression in response to
GAL4-VP16 but the increase in GFAPe mRNA was less
pronounced (Figure 8C and data not shown).
Accordingly, the ratio between the diﬀerent GFAP
mRNAs was altered by GAL4-VP16 (Figure 8C). For
both minigenes the GFAPa/GFAPe mRNA ratio was
increased, the GFAPe/GFAPk ratio was decreased, and
the GFAPa/GFAPk mRNA ratio was constant
(Figure 8C). Notably, the E7pA/E9pA ratio was not
altered signiﬁcantly after induction with GAL4-VP16
(Figure 8C). In conclusion, E7pA signal selection seems
to occur at the same frequency independent of the
transcriptional rate, at least under the conditions exam-
ined, whereas the frequency of intron 7a 30-splice site
usage did not increase proportionally.
DISCUSSION
The occurrence of alternative C-termini of proteins may
serve important functions and to achieve this, a complex
scenario of regulatory events is required. Simple addition
of a diﬀerentially used terminal exon is rarely possible due
to ‘nonsense mediated mRNA decay’ [NMD, reviewed in
(47)]. Regulation through nonsense mediated decay
implies that the stop codon must be located within the
ultimate or at the end of the penultimate exon; otherwise
the mRNA will be subjected to degradation. Generation
of a new C-terminal end of a protein by skipping of two or
more terminal exons will therefore require the use of an
alternative polyadenylation site in combination with the
new stop codon or a complex alternative splicing scenario.
Two types of alternative polyadenylation events occur at a
high frequency in the human genome: the inclusion of
a composite terminal exon, which is an exon extended due
to the lack of 30-splice site usage and which contains an
intrinsic polyadenylation signal; or inclusion of an
alternatively used terminal exon with an intrinsic poly-
adenylation signal (48). The eﬃciency of the alternative
polyadenylation and splice site skipping/usage determines
the eﬃciency of alternative 30-processing. Alternative
GFAP 30-end formation uses both of these alternative
polyadenylation events. The GFAPe mRNA is generated
through usage of the skipped terminal exon 7a and
GFAPk mRNA through inclusion of intron 7a and exon
7a as the composite terminal exon 7b.
To identify regulatory events controlling the GFAP
30-end formation we constructed a GFAP minigene
to mimic endogenous GFAP regulation and to map
cis-elements and trans-factors involved in this regulation.
The abundance of the derived GFAP transcripts was
measured by real-time RT–PCR. A clear limitation in
such analysis is that they provide only steady-state values
of the mRNA amounts based on the dynamic balance
between transcription, polyadenylation and mRNA
degradation. In this line the mRNA stability for the
minigene-derived transcripts was examined. We found no
evidence of stability diﬀerences for the three diﬀerent
GFAP transcripts. Accordingly, mRNA stability diﬀer-
ences cannot be linked to the use of one particular
polyadenylation signal. We note that experiments arrest-
ing transcription in astrocyte cell cultures indicated an
equal stability for the endogenous GFAP transcripts as
well (data not shown). The RT–PCR analysis of the
expression pattern of the various mRNAs showed that the
GFAPa/GFAP  mRNA, GFAPa/GFAPk mRNA and
E9pA/E7pA ratios are lower than the ratios for endoge-
nous GFAP mRNA observed in brain tissue and derived
cell lines. This discrepancy was not dependent on the
30-length of the construct or the lack of translation from
the construct. We note the possible absence of putative
regulatory elements located between exon 1 and exon 7 of
the GFAP gene and which could have inﬂuence on the
splicing and polyadenylation events. Another obvious
possibility is the lack of the correct transcriptional
environment. Stable integration of the GFAP minigene
into the genome of N2A cells resulted in GFAP mRNA
ratios comparable to the values determined from transient
analysis (data not shown). Thus, the ratio diﬀerences
between the endogenous and the minigene expressed
GFAP mRNA cannot be assigned solely to eﬀects from
transient experiments. We note that the GFAP gene is one
of the most highly transcribed gene in maturate astrocytes
(49). In this line, it will be interesting to examine 30-
processing also in the transcriptional regulatory context of
chromatin in cells of astrocytic lineages.
It has become evident that splicing and polyadenylation
can be coupled events that occur cotranscriptionally
(15,16). Usage of the native GFAP promoter or the
SV40 promoter in cells of astrocytic lineages did not
change the GFAP isoform ratios, and the eﬀect of
diﬀerent mutations analysed in this report was similar in
the context of these two diﬀerent promoters (Figure 8 and
data not shown). However, we note that minigenes
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promoters contain altered GFAP transcript ratios
(Figure 8). VP16 stimulates both initiation of transcription
and elongation processivity (45,50). A processive elonga-
tion will help RNA Polymerase II elongate past sites
where it is prone to stall or pause (44,51). The use
of promoters inducible by VP16 showed that the
E7pA/E9pA ratio is constant after inducing processive
elongation. It indicates that exon 7a poly(A) site selection
functions independently of the processivity of RNA
Polymerase II. Participants of this independence could
be regulatory sequences around the E7pA signal.
We identiﬁed a sequence situated downstream of the
E7pA signal, the PRE, which is similar to a polyadenyla-
tion regulatory motif identiﬁed in other genes, and
we showed that this sequence contributes to GFAP
30-formation through support of the E7pA signal usage.
Four other regions surrounding the E7pA sequence and
conserved to the mouse GFAP exon 7a were similarly
analysed but no eﬀect on either splicing or polyadenyla-
tion was detected (data not shown). The increased ratio of
polyadenylation from E7pA after transcriptional induc-
tion by VP16 was associated with a lower ratio of intron
7a 30-splice site usage. This could be mechanistically
explained by a limitation in the recruitment of splice
factors. Of the diﬀerent trans-factors examined only the
PTB protein had a proportional eﬀect on splicing and
polyadenylation of exon 7a. Thus, ectopic PTB expression
did neither resemble the eﬀect achieved by optimizing the
polypyrimidine tract in the intron 7a 30-splice site, nor the
eﬀect achieved by SR protein overexpression.
By mutating the AAUAAA hexamer in exon 7a, the
GFAPa/GFAPe, GFAPa/GFAPk and E9pA/E7pA ratios
were increased. If inclusion of exon 7a could still occur
without an AAUAAA hexamer in exon 7a, an mRNA
containing a large exon starting at the 30-splice site of
intron 7a or at the position of the 30-splice site in intron 6
and ending at the 50-splice site of intron 9 could be
expected. No such transcripts continuing downstream of
the poly(A) signal were detected. This was also observed
after depleting cells for Rrp6 of the nuclear RNA
exosome. Altogether, this shows that splicing at the
30-splice site in intron 7a does not occur without a
functional poly(A) signal in exon 7a. This is in accordance
with previous in vitro studies where mutation of the
AAUAAA hexamer depresses splicing of the last intron
(20,21). Further studies are needed to determine whether
this is a direct eﬀect of splicing or rather a consequence of
a competitive removal of the entire intron 7 in the absence
of the E7pA.
The 30-splice site of GFAP intron 7a is a weak splice site
based on score matrice calculations (http://www.fruitﬂy.
org/seq_tools/splice.html, (52)). This weakness can be
attributed to the presence of an imperfect consensus
polypyrimidine tract. To analyse if the function of the
E7pA signal depends on a functional 30-splice site in
intron 7a, an RT–PCR analysis was performed using
RNA expressed from a minigene without a 30-splice site.
As expected, no transcripts corresponding to GFAPe
mRNA was observed. Furthermore, no transcripts con-
tinuing downstream of the poly(A) signal was detected
while mRNA representing GFAPk was present. Thus, the
poly(A) signal is functional without the intron 7a 30-splice
site. Quantitative analysis revealed a marked reduction in
transcripts polyadenylated at the E7pA when the exon 7a
splice site is mutated. This reduction was larger than
would be expected if it was a result of a conversion to
GFAPa mRNA of the amount of GFAPk mRNA
normally expressed. A simple explanation could be that
the intron 7a 30-splice site supported the selection of the
E7pA site and in the absence of this splice site other
sequence motifs, as for example the 30-splice site in intron
6, to some extent could still support the usage of E7pA.
The interrupted polypyrimidine tract upstream of the
intron 7a 30-splice site might impair U2AF binding.
Optimizing the polypyrimidine tract strengthened the
splice site, and the expression of GFAPe mRNA was
increased relative to GFAPk mRNA. More surprisingly,
the E7pA/E9pA ratio was increased pointing to a positive
eﬀect also on exon 7a polyadenylation when the pyrimi-
dine tract was optimized. PAP interacts with U2AF
in vitro and stimulates binding of U2AF to a weak
pyrimidine tract of a terminal intron (24). The pyrimidine
tract, and not the splice site in the terminal intron of the
human b-globin gene, stimulates polyadenylation in vitro
and in vivo (23). Similar interactions could account for the
coupling of the 30-splice site in GFAP intron 7a with the
E7pA signal.
Three exon 7a ESEs were found to be involved in the
regulation of the alternative GFAP 30-processing. The
contribution from ESE1 and ESE3 was cell type
independent. An ESE1/ESE3 double mutant showed the
same mRNA ratios as were observed for the individual
ESE mutations, which suggests that the ESE1 and ESE3
are not functional at the same time. This is in accordance
with observations by Hertel and Maniatis who found that
even though alternatively spliced exons often have several
regulatory cis-elements, there is always only one active at a
time, the others serving as back-up if the speciﬁc SR
protein is not present (53). The co-expression of the
GFAP wt minigene and plasmids expressing diﬀerent SR
proteins with the potential of binding to these ESE
elements resulted in a decrease of the GFAPe/GFAPk
mRNA ratio while the E7pA/E9pA ratio increased. These
ﬁndings indicate that SR proteins could have an eﬀect not
only on the splicing of intron 7a but also on the E7pA
signal selection. Furthermore, mutation of ESE elements
in the presence of an optimized pyrimidine tract results in
a decreased E7pA/E9pA ratio, which also could indicate
that ESE cis-elements have a role in enhancing poly-
adenylation (Figure 6D). Previously, it was shown that the
SR protein SRp20 facilitates the use of the poly(A) signal
in exon 4 of the calcitonin/calcitonin gene-related peptide
(CT/CGRP) pre-mRNA (25). Similar interactions could
account for our observations that SR proteins and ESEs
are positively involved in the selection of the E7pA signal.
The increased E7pA usage mediated by the SR proteins
was not proportionally coupled to an increase in exon 7a
splicing. Either the examined factors not limiting factors
in the splice reaction or their overexpression directly
disturbs splice complex formation. We note however that
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eﬀect on the other splicing events in the cells.
Together, the presented results support a model for the
alternative GFAP 30-end formation wherein the activity
of the GFAP exon 7a polyadenylation signal, and not
30-splice site usage, is the primary determinant for the
fraction of GFAP transcripts terminated by exon 7a.
Subsequently, these GFAP transcripts can be spliced using
the intron 7a 30-splice site. The eﬃciency of these events
are tightly regulated, both individually and coupled, which
results in a possibility to precisely modulate the level of the
three GFAP isoforms. Terminal stress and Ca
2+ levels are
two examples of environmental conditions previously
described to be of importance to the GFAP ﬁlament
organization. The direct eﬀect on the GFAP ﬁlament
structure through for example GFAP phosphorylation
and the ﬁlament association of heat-shock factors is
evident. The eﬀect on the relative ratio of the GFAP
transcripts described here can be important as we note
that the GFAP isoforms have diﬀerent functional proper-
ties in relation to ﬁlament assembly. Opposite to GFAPa
the GFAPe and GFAPk isoforms have no intrinsic
ﬁlament forming capacity. At low-expression ratios, the
GFAPe and GFAPk isoforms assemble into GFAP
ﬁlaments but interfere at high-expression ratios with the
GFAP intermediate ﬁlament structure. Further delinea-
tion of the factors and mechanisms determining the GFAP
30-end processing will be important in the functional
characterization of these important GFAP isoforms.
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